Quantitative Evaluation of HIV Prevention Programs Quantitative Evaluation of HIV Prevention Programs

Quantitative Evaluation of HIV Prevention Programs

    • $72.99
    • $72.99

Publisher Description

How successful are HIV prevention programs? Which HIV prevention programs are most cost effective? Which programs are worth expanding and which should be abandoned altogether? This book addresses the quantitative evaluation of HIV prevention programs, assessing for the first time several different quantitative methods of evaluation.

The authors of the book include behavioral scientists, biologists, economists, epidemiologists, health service researchers, operations researchers, policy makers, and statisticians. They present a wide variety of perspectives on the subject, including an overview of HIV prevention programs in developing countries, economic analyses that address questions of cost effectiveness and resource allocation, case studies such as Israel’s ban on Ethiopian blood donors, and descriptions of new methodologies and problems.

GENRE
Professional & Technical
RELEASED
2008
October 1
LANGUAGE
EN
English
LENGTH
352
Pages
PUBLISHER
Yale University Press
SELLER
Yale University
SIZE
39.2
MB

More Books Like This

Decision Analytics and Optimization in Disease Prevention and Treatment Decision Analytics and Optimization in Disease Prevention and Treatment
2018
Seroprevalence of Human Immunodeficiency Virus and Syphilis Infections Among Patients Attending the STD, Gyn. And Obs., ANC Clinics of Northern India: Observations from Seven Rounds of Sentinel Surveillance (1998-2004). Seroprevalence of Human Immunodeficiency Virus and Syphilis Infections Among Patients Attending the STD, Gyn. And Obs., ANC Clinics of Northern India: Observations from Seven Rounds of Sentinel Surveillance (1998-2004).
2006
Iatrogenic Harm Following "HIV" Testing (Report) Iatrogenic Harm Following "HIV" Testing (Report)
2010
Board Review in Preventive Medicine and Public Health Board Review in Preventive Medicine and Public Health
2023
Factors Associated with Syringe Sharing Among Users of a Medically Supervised Safer Injecting Facility. Factors Associated with Syringe Sharing Among Users of a Medically Supervised Safer Injecting Facility.
2005
Clinical Trials Clinical Trials
2017